Search
Galectin Therapeutics Inc
GALTAdd to Watchlist
3.620USD
-0.090-2.43%
Close 10-16 16:00（ET）
238.41MMarket Cap
LossP/E TTM
Galectin Therapeutics Inc (GALT) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Galectin Therapeutics Inc in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
11.000USD+198.10%
GALT Analyst Recommendation Trends
In the current month, GALT has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. GALT average Analyst price target in the last month is 11.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
Financial Forecasting
Based on analysts' estimates, GALT EPS is projected to reach -0.050 in FY2026Q3, following reported EPS of -0.139 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.10
-0.06
-0.09
-0.05
-0.05
Actual
-0.09
-0.08
-0.14
--
--
Surprise
+14.09%
-28.38%
-54.76%
--
--
FAQs
What is Galectin Therapeutics Inc's price target?
Analysts forecast that Galectin Therapeutics Inc's price target is USD 6.00, with the highest forecast at USD 6.00 and the lowest forecast at USD 6.00.
How have Galectin Therapeutics IncGALT's recent earnings per share performed?
The market expectation was USD -0.14, while Galectin Therapeutics IncGALT's earnings per share (EPS) for the previous quarter was USD -0.08. EPS for the next quarter is expected at USD -0.05.
What is the analyst rating for Galectin Therapeutics Inc?
Based on the ratings of Galectin Therapeutics Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.